Main Menu

News and features

The ICR’s media team works to increase the profile of the organisation by showcasing the cutting-edge research carried out by our scientists and development initiatives. 

For more information you can always contact our media team, or visit our press release archive to view a list of our press releases. 


Statement in response to NICE approval of dabrafenib for the treatment of certain cases of advanced melanoma 17

Professor Paul Workman comments on final draft guidance from NICE recommending dabrafenib for the treatment of advanced melanoma which tests positive for the BRAF V600 mutation. Find out more

Blood test could identify when cancer treatment has become detrimental 17

Some treatments for prostate cancer, while initially effective at controlling the disease, not only stop working over time but actually start driving tumour growth, a major new study shows. Find out more

Genetic testing can identify men at six-fold increased risk of prostate cancer 14

Scientists can now explain a third of the inherited risk of prostate cancer, after a major international study identified 23 new genetic variants associated with increased risk of the disease. Find out more

See all news articles


Exploiting the cell cycle to improve radiotherapy outcomes 20

One of the crucial signalling networks that often go awry in cancer are those that respond to DNA damage and regulate the cell cycle progression. But now researchers are turning this to their advantage, and are attacking cancer by targeting one of the very processes that drives it – a faulty DNA repair response. Find out more

Darwinian evolution: from dinosaurs to cancer drug resistance 15

Birds evolving from dinosaurs, fish emerging from the sea, and hominids adopting an upright posture – all are iconic examples of evolution. On the surface they don’t have a great deal to do with cancer, but the process underlying them both — natural selection — is identical. Find out more

The story of abiraterone 11

Abiraterone is one of the ICR’s biggest success stories: the first treatment shown to be effective in men with advanced prostate cancer. But it took almost 20-years of hard work to take the drug from an initial idea to the clinic, where it now transforms the lives of more than 25,000 patients every year. Find out more

See all feature articles
We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you are agreeing to our use of cookies on your device as described in our cookie policy. You can change your cookie settings at any time but parts of our site will not function correctly without them.